Table 1. Clinical trials of mesenchymal stem cell therapy for cardiovascular diseases.

Reference	Disease	Phase	No. of patients	MSC source	Route	Primary endpoints
Chen et al.10	AMI	I	69	Allo-BM	Intracoronary	Improved
Chen et al.11	IHD	I	46	Allo-BM	Intracoronary	Improved
Katritsis et al.15	AMI	I	22	Allo-BM	Intracoronary	Improved
Katritsis et al.14	AMI	I	5	Allo-BM	Intracoronary	Improved
Yang et al.16	AMI	I	16	Allo-BM	Intracoronary	Improved
Zeinaloo et al.17	AMI	I	1	Allo-BM	Intracoronary	Improved
Hare et al.13	AMI	I	53	Allo-BM	IV	Improved
Friis et al.12	IHD	I	31	Auto-BM	IM	improved
Hare et al.18	IHD	I/II	30	Atuo/allo-BM	IM	Improved
Houtgraaf et al.19	IHD	I/II	14	ADRCs	Intracoronary	improved

ADRCs, adipose tissue-derived regenerative cells; Allo-BM, allogenic bone marrow; AMI, acute myocardial infarction; Auto-BM, autologous bone marrow; IHD, ischemic heart disease; IM, intra-myocardial; IV, intravenous; MSCs, mesenchymal stem cells.